At-home Colon Cancer Screening Test Covered for 1199SEIU Patients

In an effort to raise the colon cancer screening rates of our members, the Benefit Funds now provide coverage for the Cologuard Collection Kit. As you know, early detection is key to successfully treating colon cancer, and our members have screening rates below the national average. Cologuard is an easy-to-use, at-home screening method that requires no special preparation, dietary restrictions or medication changes. We encourage you to discuss this new alternative with your 1199SEIU patients for whom it may be appropriate. We understand that Cologuard may not be the right option for all patients, including those at high risk of developing colon cancer. Please note that we require prior authorization before prescribing the Cologuard test. For more information about the Cologuard Collection Kit, please visit www.CologuardTest.com.

More Provider Connections

Enhancements to eviCore Streamline Prior Authorization Process

The 1199SEIU Benefit Funds are enhancing their partnership with the eviCore Healthcare Review Program to help ensure that your 1199SEIU patients receive the most consistent standard of cancer care. These changes, which will go into effect on October 1, include...

ClaimsXten Select Frequently Asked Questions (FAQs)

ClaimsXten Select is a clinically based claims-editing software solution that advances claims-auditing capabilities and resolves limitations in the current ClaimCheck software. ClaimsXten Select offers clinical coding logic and rules-based claims management with the...

Benefit Funds to Upgrade Our Claims Auditing Software

Effective March 1, the Benefit Funds will upgrade our claims-auditing platform, from ClaimCheck to ClaimsXten, to meet our needs for a more comprehensive and well-known solution that is used by many payers to adjudicate applicable claims according to prevailing...

Share This